Bulletin
Investor Alert

London Markets Open in:

BioLife Solutions Inc.

NAS: BLFS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 8, 2022, 7:23 p.m.

/zigman2/quotes/207858501/composite

$

22.32

Change

+1.06 +4.99%

Volume

Volume 9,611

Quotes are delayed by 20 min

/zigman2/quotes/207858501/composite

Previous close

$ 21.49

$ 21.26

Change

-0.23 -1.07%

Day low

Day high

$20.73

$21.64

Open

52 week low

52 week high

$10.40

$60.67

Open

Company Description

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and...

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Valuation

Price to Sales Ratio

12.04

Price to Book Ratio

3.25

Enterprise Value to EBITDA

-60.41

Enterprise Value to Sales

6.27

Efficiency

Total Asset Turnover

0.30

Liquidity

Current Ratio

3.12

Quick Ratio

2.41

Cash Ratio

1.73

Profitability

Gross Margin

24.21

Operating Margin

-24.70

Pretax Margin

-23.29

Net Margin

-6.41

Return on Assets

-1.94

Return on Equity

-2.23

Return on Total Capital

-8.14

Capital Structure

Total Debt to Total Assets

4.85

Officers and Executives

Name Age Officer Since Title
Mr. Michael P. Rice 58 2006 Chief Executive Officer & Director
Mr. Roderick de Greef 59 2000 Chief Financial Office & Director
Mr. Troy Wichterman - 2015 Vice President-Finance
Dr. Aby J. Mathew 47 1998 Chief Scientific Officer & Executive VP
Mr. Marcus Schulz 41 2019 Vice President-Sales

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/17/2022 Michael P. Rice
CEO; Director
779   Award at $0 per share. 0
07/17/2022 Aby J. Mathew
EVP & Chief Scientific Officer
635   Award at $0 per share. 0
07/17/2022 Roderick de Greef
COO & President
828   Award at $0 per share. 0
07/17/2022 Karen Foster
Chief Quality Officer
430   Award at $0 per share. 0
07/17/2022 Troy Wichterman
Chief Financial Officer
362   Award at $0 per share. 0
07/12/2022 Roderick de Greef
COO & President
9,158   Disposition at $15.79 per share. 144,604
07/12/2022 Marcus Schulz
Chief Revenue Officer
254   Disposition at $15.79 per share. 4,010
07/03/2022 Michael P. Rice
CEO; Director
847   Award at $0 per share. 0
07/03/2022 Aby J. Mathew
EVP & Chief Scientific Officer
690   Award at $0 per share. 0
07/03/2022 Roderick de Greef
COO & President
900   Award at $0 per share. 0
07/03/2022 Karen Foster
Chief Quality Officer
468   Award at $0 per share. 0
07/03/2022 Troy Wichterman
Chief Financial Officer
394   Award at $0 per share. 0
07/01/2022 Joseph Schick
Director
409   Award at $0 per share. 0
07/01/2022 Amy DuRoss
Director
389   Award at $0 per share. 0
07/01/2022 Rachel H. Ellingson
Director
341   Award at $0 per share. 0
07/01/2022 Joydeep Goswami
Director
369   Award at $0 per share. 0
06/28/2022 Michael P. Rice
CEO; Director
889   Disposition at $14.86 per share. 13,210
06/28/2022 Aby J. Mathew
EVP & Chief Scientific Officer
704   Disposition at $14.86 per share. 10,461
06/28/2022 Karen Foster
Chief Quality Officer
598   Disposition at $14.86 per share. 8,886
06/28/2022 Todd Berard
Chief Marketing Officer
495   Disposition at $14.86 per share. 7,355
06/24/2022 Troy Wichterman
Chief Financial Officer
456   Disposition at $15.95 per share. 7,273
06/19/2022 Michael P. Rice
CEO; Director
899   Award at $0 per share. 0
06/19/2022 Aby J. Mathew
EVP & Chief Scientific Officer
733   Award at $0 per share. 0
06/19/2022 Roderick de Greef
COO & President
955   Award at $0 per share. 0
06/19/2022 Karen Foster
Chief Quality Officer
497   Award at $0 per share. 0
06/19/2022 Troy Wichterman
Chief Financial Officer
418   Award at $0 per share. 0
06/05/2022 Michael P. Rice
CEO; Director
901   Award at $0 per share. 0
06/05/2022 Aby J. Mathew
EVP & Chief Scientific Officer
735   Award at $0 per share. 0
06/05/2022 Roderick de Greef
COO & President
957   Award at $0 per share. 0
06/05/2022 Karen Foster
Chief Quality Officer
498   Award at $0 per share. 0
06/05/2022 Troy Wichterman
Chief Financial Officer
419   Award at $0 per share. 0
06/01/2022 Joseph Schick
Director
374   Award at $0 per share. 0
06/01/2022 Amy DuRoss
Director
343   Award at $0 per share. 0
06/01/2022 Rachel H. Ellingson
Director
311   Award at $0 per share. 0
06/01/2022 Joydeep Goswami
Director
343   Award at $0 per share. 0
05/27/2022 Michael P. Rice
CEO; Director
749   Disposition at $14.53 per share. 10,882
05/27/2022 Aby J. Mathew
EVP & Chief Scientific Officer
351   Disposition at $14.53 per share. 5,100
05/27/2022 Karen Foster
Chief Quality Officer
174   Disposition at $14.53 per share. 2,528
05/27/2022 Troy Wichterman
Chief Financial Officer
43   Disposition at $14.53 per share. 624
/news/latest/company/us/blfs

MarketWatch News on BLFS

  1. BioLife Solutions stock price target cut to $34 from $48 at B. Riley

    7:46 a.m. May 17, 2022

    - Tomi Kilgore

  2. BioLife Solutions stock price target cut to $30 from $60 at Maxim Group

    7:50 a.m. May 12, 2022

    - Tomi Kilgore

  3. BioLife Solutions stock price target cut to $30 from $60 at KeyBanc Capital

    6:35 a.m. May 10, 2022

    - Tomi Kilgore

  4. BioLife Solutions upgraded to outperform from perform at Oppenheimer

    7:28 a.m. April 25, 2022

    - Tomi Kilgore

  5. BioLife Solutions stock price target raised to $60 from $50 at KeyBanc Capital

    6:03 a.m. Aug. 13, 2021

    - Tomi Kilgore

  6. BioLife Solutions stock price target raised to $61.00 from $35.50 at B. Riley

    8:16 a.m. March 24, 2021

    - Tomi Kilgore

  7. BioLife Solutions stock price target raised to $60 from $40 at Maxim Group

    8:20 a.m. March 23, 2021

    - Tomi Kilgore

  8. BioLife Solutions stock price target raised to $50 from $40 at KeyBanc Capital

    6:16 a.m. March 23, 2021

    - Tomi Kilgore

  9. BioLife Solutions, Nikola See Activist Action

    10:31 p.m. Dec. 4, 2020

    - Barron's Online

  10. BioLife Solutions started at overweight with $40 stock price target at KeyBanc Capital

    7:28 a.m. Nov. 10, 2020

    - Tomi Kilgore

  11. BioLife stock price target raised to $40 from $32 at Maxim Group

    9:14 a.m. Nov. 6, 2020

    - Tomi Kilgore

  12. BioLife Solutions downgraded to perform from outperform at Oppenheimer

    8:37 a.m. Sept. 22, 2020

    - Tomi Kilgore

  13. BioLife Solutions downgraded to hold from buy at Benchmark

    6:15 a.m. Aug. 11, 2020

    - Tomi Kilgore

  14. BioLife Solutions stock price target raised to $26 from $18 at Maxim Group

    8:17 a.m. July 8, 2020

    - Tomi Kilgore

  15. BioLife Solutions started at buy with $24 stock price target at Benchmark

    8:42 a.m. Feb. 19, 2020

    - Tomi Kilgore

  16. BioLife Solutions started at outperform with $22 stock price target at Oppenheimer

    8:40 a.m. Nov. 21, 2019

    - Tomi Kilgore

  17. Letters to Barron’s

    9:30 p.m. Oct. 4, 2019

    - Barron's Online

  18. Our Roundtable Experts Pick 14 Biotech Stocks

    6:10 p.m. Oct. 2, 2019

    - Barron's Online

  19. BioLife Solutions stock price target raised to $28 from $22 at B. Riley FBR

    8:37 a.m. June 10, 2019

    - Tomi Kilgore

  20. Loading more headlines...
/news/nonmarketwatch/company/us/blfs

Other News on BLFS

  1. Notable earnings after Tuesday's close

    5:35 p.m. Aug. 8, 2022

    - Seeking Alpha

  2. Cryoport: To Resume Aggressive Growth

    3:18 p.m. May 11, 2022

    - Seeking Alpha

  3. Notable earnings after Monday's close

    5:35 p.m. May 8, 2022

    - Seeking Alpha

  4. Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates

    5:15 p.m. May 5, 2022

    - Zacks.com

  5. NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates

    6:35 p.m. May 4, 2022

    - Zacks.com

  6. New Strong Sell Stocks for May 2nd

    7:47 a.m. May 2, 2022

    - Zacks.com

  7. BioLife Solutions gains as Oppenheimer upgrades on valuation

    10:23 a.m. April 25, 2022

    - Seeking Alpha

  8. BioLife: Can This Company Successfully Turn Around?

    3:55 p.m. April 18, 2022

    - Seeking Alpha

  9. Cryoport: An Industry Leader Basking In Industry Tailwinds

    9:47 a.m. April 15, 2022

    - Seeking Alpha

  10. 10-K: BIOLIFE SOLUTIONS INC

    4:48 p.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. New Strong Sell Stocks for March 31st

    6:44 a.m. March 31, 2022

    - Zacks.com

  12. BioLife Solutions receives Nasdaq notice for noncompliance

    2:08 a.m. March 21, 2022

    - Seeking Alpha

  13. Temporary Setbacks At BioLife

    4:31 p.m. March 2, 2022

    - Seeking Alpha

  14. BioLife Solutions Q4 2021 Earnings Preview

    6:35 p.m. Feb. 27, 2022

    - Seeking Alpha

  15. Loading more headlines...

At a Glance

BioLife Solutions, Inc.

3303 Monte Villa Parkway

Suite 310

Bothell, Washington 98021

Phone

1 4254021400

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$119.16M

Net Income

$-7.64M

Employees

437.00

/news/pressrelease/company/us/blfs

Press Releases on BLFS

  1. BioLife Solutions Reports First Quarter 2022 Financial Results

    4:03 p.m. May 9, 2022

    - PR Newswire - PRF

  2. BioLife Solutions Announces Third Quarter 2021 Financial Results

    5:05 p.m. Nov. 11, 2021

    - PR Newswire - PRF

  3. BioLife Solutions Announces Executive Management Changes

    4:06 p.m. Nov. 5, 2021

    - PR Newswire - PRF

  4. Loading more headlines...
Link to MarketWatch's Slice.